Petition · past parliament
Reinstate bevacizumab (Avastin) for cervical cancer on the Cancer Drugs Fund
Closed
1,560 signatures
What the petition asks
Jo’s Cervical Cancer Trust is calling for the drug bevacizumab (Avastin) for cervical cancer to be reinstated onto the Cancer Drugs Fund (CDF) list after the announcement that it will be de-listed for cervical cancer treatment from the 4th November 2015.
Without bevacizumab, hundreds of women annually with late stage cervical cancer will be denied a drug that has shown to increase the median survival by 3.7 months with a small impact on quality of life.
The removal of bevacizumab, which had just started to fulfill a large and unmet need, will result in a hugely detrimental impact on end of life for cervical cancer patients.
We’re calling on NHS England and Pharma to resolve this issue and come to an agreement on affordability.
The removal of bevacizumab, which had just started to fulfill a large and unmet need, will result in a hugely detrimental impact on end of life for cervical cancer patients.
We’re calling on NHS England and Pharma to resolve this issue and come to an agreement on affordability.
Timeline
| 22 Sep 2015 | Petition opened for signatures |
| 22 Mar 2016 | Closed to new signatures |
Key facts
Signatures
1,560
Status
Closed
Opened
22 Sep 2015
Closed
22 Mar 2016
Follow this petition
Sign in to get an email when the government responds, a debate is scheduled or held, or the petition closes.
Source: the official petition page. Last checked 15 Jul 2026.